axicabtagene ciloleucel
gilead sciences,daiichi sankyo
['axi-cel']
live from #asco22: findings presented by show favorable outcomes with axi-cel regardless of race, ethnicity. 
CGTLive™ delivers quality and relevant information to healthcare professionals on cell, gene, regenerative, and engineered medicines to ultimately improve care.